Measuring economic impact of applying daily average consumption limits.
CONCLUSION: Implementing DACON limits on selected medications provided a cost avoidance of approximately $720,000 over a 3-month period with limited interruption to patient access and relatively low administrative burden. This reduction could result in annualized savings of nearly $3 million.
PMID: 24456317 [PubMed - indexed for MEDLINE]
Source: Journal of Managed Care Pharmacy - Category: Drugs & Pharmacology Tags: J Manag Care Pharm Source Type: research
More News: Abilify | Cymbalta | Drugs & Pharmacology | Medicare | Niacin | Niaspan | Temazepam | Vitamin B3